Tools & Techniques

Synthetic control arms are emerging as a valuable solution for clinical trials where using traditional placebo groups is difficult, unethical, or impractical.

Efforts to move beyond long-term steroid use are accelerating, with growing awareness of steroid toxicity, new tools to guide tapering, and emerging therapies offering safer alternatives.

Intuitive software supports 24 hours of continuous runtime and easy analysis of complex high-throughput datasets

A breakthrough from AI|ffinity and NexMR was achieved with a 100-fold affinity improvement in the initial round of drug discovery using ultrafast NMR screening and AI-driven lead generation against intrinsically disordered protein targets.

Optimizing CRISPR delivery is essential to unlocking its full potential in drug discovery, enabling efficient, precise, and reproducible gene editing across diverse cell types and experimental contexts.

Machine learning-powered image analysis makes it possible to automatically and reliably quantify complex 3D cell structures.

Bio-Rad Laboratories, Inc has launched four new Droplet Digital PCR platforms.

Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology

To help clinicians monitor slow-healing chronic wounds, researchers created the iCares device and tested it in 20 people with a variety of wounds.

High-throughput, automated approaches are improving how researchers handle, monitor, and analyze complex 3D cell models.

Take a closer look at modern techniques that reveal when, where, and how neurons communicate in real time.

Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market